Drugs for Dystonia, Focal, Task-Specific (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 31)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Propranolol |
Approved, Investigational |
Phase 4 |
|
525-66-6 |
4946 |
Synonyms:
(+-)-Propranolol
(1)-1-(Isopropylamino)-3-(naphthyloxy)propan-2-ol
(R)-(+)-propranolol
(S)-(-)-PROPRANOLOL
1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol
1-(1-Naphthyloxy)-2-hydroxy-3-(isopropylamino)propane
1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol
1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol
1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol
1-(isopropylamino)-3-(1-Naphthyloxy)propan-2-ol
1-(naphthalen-1-yloxy)-3-(propan-2-ylamino)propan-2-ol
1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol
13013-17-7
1-Isopropylamino-3-(1-naphthyloxy)-2-propanol
1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)- (9CI)
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, (+-)- (9CI)
3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol
4199-09-1
4199-10-4
525-66-6
AB00053537
AC1L1JA4
AC1Q1QBV
AC1Q1QC0
AKOS000588816
Anaprilin
Anapriline
Angilol
Apsolol
Avlocardyl
AY 64043
AY-20694
Bedranol
Beprane
Berkolol
Beta Neg
Betachron
Betadren
Betalong
Beta-Neg
beta-Propranolol
Beta-Propranolol
Beta-Tablinen
Beta-Timelets
Bio-0732
Bio1_000367
Bio1_000856
Bio1_001345
BPBio1_001040
b-Propranolol
BRD-A10070317-003-06-9
BSPBio_000944
BSPBio_002682
C07407
C16H21NO2
Cardinol
Caridolol
CBDivE_006180
CCRIS 3082
CHEBI:8499
CHEMBL27
CID4946
cMAP_000071
Corpendol
D,L-Propranolol
D08443
DB00571
Deralin
Dexpropranolol
DivK1c_000023
Dl-Propranolol Hydrochloride
DL-Propranolol hydrochloride
Dociton
Duranol
Efektolol
EINECS 208-378-0
EINECS 235-867-6
Elbrol
etalong
Etalong
Euprovasin
Frekven
Herzbase
HMS2090L21
Hydrochloride, propranolol
ICI 45520
IDI1_000023
Ikopal
Inderal
Inderal hydrochloride
Inderal La
Inderalici
Inderex
Inderide
INDERIDE-40/25
INDERIDE-80/25
|
Inderol
Indobloc
Innopran XL
InnoPranXL
Intermigran
KBio1_000023
KBio2_002515
KBio2_005083
KBio2_007651
KBio3_001766
KBio3_001902
KBio3_002993
KBioGR_001347
KBioGR_001684
KBioGR_002515
KBioSS_002523
Kemi
Kemi S
L000679
Lopac0_000896
LS-122410
LS-184129
Migrastat
MolPort-001-794-623
Naprilin
NCGC00015798-07
NCGC00024690-02
NCGC00024690-03
NINDS_000023
NSC91523
Obsidan
Obzidan
Oposim
Oprea1_304193
PDSP1_000767
PDSP1_001607
PDSP1_001608
PDSP2_000755
PDSP2_001591
PDSP2_001592
Pranolol
Prano-Puren
Prestwick0_000952
Prestwick1_000952
Prestwick2_000952
Prestwick3_000952
Pronovan
Propanalol
Propanix
Propanolol
Propanolol [INN-Spanish]
Prophylux
Propranalol
propranolol
Propranolol
Propranolol (INN)
Propranolol (TN)
Propranolol [INN:BAN]
Propranolol Hcl
Propranolol Hcl Intensol
Propranolol hydrochloride
Propranolol Hydrochloride
propranololo
Propranololo
Propranololo [DCIT]
Propranololum
Propranololum [INN-Latin]
Propranur
Proprasylyt
Pylapron
R,S-Propranolol Hydrochloride
Racemic propranolol
Rapynogen
Reducor
Reducor line
Reducor Line
Rexigen
Sagittol
Sawatal
Servanolol
Sloprolol
SPBio_001361
SPBio_001658
SPBio_003093
Spectrum2_001301
Spectrum2_001699
Spectrum3_000883
Spectrum3_001071
Spectrum4_000974
Spectrum4_001222
Spectrum5_000751
STK735510
Sumial
Tesnol
UNII-9Y8NXQ24VQ
β-propranolol
β-Propranolol
|
|
2 |
|
incobotulinumtoxinA |
|
Phase 4 |
|
|
|
3 |
|
rimabotulinumtoxinB |
|
Phase 4 |
|
|
|
4 |
|
Adrenergic beta-Antagonists |
|
Phase 4 |
|
|
|
5 |
|
Antihypertensive Agents |
|
Phase 4 |
|
|
|
6 |
|
Adrenergic Antagonists |
|
Phase 4 |
|
|
|
7 |
|
Adrenergic Agents |
|
Phase 4 |
|
|
|
8 |
|
Vasodilator Agents |
|
Phase 4 |
|
|
|
9 |
|
Anti-Arrhythmia Agents |
|
Phase 4 |
|
|
|
10 |
|
abobotulinumtoxinA |
|
Phase 3 |
|
|
|
11 |
|
Botulinum Toxins, Type A |
|
Phase 3 |
|
|
|
12 |
|
Pharmaceutical Solutions |
|
Phase 3 |
|
|
|
13 |
|
Amlodipine |
Approved |
Phase 2 |
|
88150-42-9 |
2162 |
Synonyms:
()-Amlodipine
(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)
-3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6-methyl-1,4-dihydropyridine
3,5-Pyridinedicarboxylic acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester
3,5-Pyridinedicarboxylic acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester
3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
3-ethyl 5-methyl 2-{[(2-aminoethyl)oxy]methyl}-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
3-Ethyl 5-methylester, (±)-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl ( -)-2-((2-aminoethoxy)methyl)-4-(2-chlorphenyl)-1,4-dihydro-6-methyl-3,5-pyridindicarboxylat
3-Ethyl-5-methyl ( -)-2-((2-aminoethoxymethyl)-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (.+/-.)-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylic acid
3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
88150-42-9
88150-47-4 (maleate (1:1))
AC1L1D26
AC1Q32ZS
AC-4535
Almirall brand OF amlodipine besilate
Ambap88150-42-9
Amlocard
amlodipine
Amlodipine
Amlodipine (INN)
Amlodipine [INN:BAN]
AMLODIPINE BASE
Amlodipine Benzenesulfonate
Amlodipine besilate
Amlodipine Besilate
Amlodipine besylate
Amlodipine Besylate
Amlodipine free base
Amlodipine Free Base
Amlodipine maleate
Amlodipine maleate (1:1)
Amlodipine, (+-)-isomer
Amlodipine, (+-)-isomer, maleate (1:1)
Amlodipine, (R)-isomer
Amlodipine, (S)-isomer, maleate (1:1)
Amlodipino
Amlodipino [Spanish]
Amlodipinum
Amlodipinum [Latin]
Amlodis
Amlopres
Amlor
|
Amvaz
AMVAZ
Astudal
BIDD:GT0810
BRD-A22032524-074-02-4
BRD-A22032524-074-03-2
BSPBio_002727
C06825
CHEBI:2668
CHEMBL1491
CID2162
Coroval
CPD000469198
D07450
DB00381
Eczacibasi brand OF amlodipine besilate
HMS2052N03
HMS2089H07
I14-0798
Intervask
Istin
KBio3_001947
KBioGR_001643
Lipinox
Lotrel
LS-131183
Mack brand OF amlodipine besilate
MLS001401409
MolPort-001-792-963
NCGC00165957-01
NCGC00165957-02
NCGC00165957-03
Norvasc
Norvasc (TN)
Pelmec
Pfizer brand OF amlodipine besilate
R,S)-Amlodipine
Racemic amlodipine
Racemic Amlodipine
SAM001246705
SMR000469198
SPBio_000351
Spectrum2_000486
Spectrum3_001004
Spectrum4_001132
Spectrum5_001550
UK-4834011
UNII-1J444QC288
|
|
14 |
|
Mexiletine |
Approved, Investigational |
Phase 2 |
|
31828-71-4 |
4178 |
Synonyms:
(+-)-1-(2,6-dimethylphenoxy)propan-2-amine
(+-)-1-(2,6-Dimethylphenoxy)propan-2-amine
(±)-1-(2,6-dimethylphenoxy)propan-2-amine
(2Rs)-1-(2,6-Dimethylphenoxy)-2-aminopropane
(2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane
1-(2',6'-dimethylphenoxy)-2-aminopropane
1-(2',6'-Dimethylphenoxy)-2-aminopropane
1-(2,6-dimethylphenoxy)-2-propanamine
1-(2,6-Dimethylphenoxy)-2-propanamine
1-(2,6-dimethylphenoxy)propan-2-amine
1-methyl-2-(2,6-xylyloxy)ethanamine
1-Methyl-2-(2,6-xylyloxy)ethanamine
1-Methyl-2-(2,6-xylyloxy)ethylamine
2-(2-aminopropoxy)-1,3-dimethylbenzene
2-(2-Aminopropoxy)-1,3-DiMethyl-Benzene Hydrochloride
31828-71-4
5370-01-4 (hydrochloride)
AB00053683
AC1L1HL7
AC1Q2BC5
AC1Q2BC6
Boehringer ingelheim brand OF mexiletine hydrochloride
BPBio1_000026
BRD-A64092382-003-04-3
BRN 2092205
BSPBio_000022
BSPBio_002254
C07220
CHEBI:115958
CHEBI:6916
CHEMBL558
CID4178
D08215
DB00379
DivK1c_000834
EINECS 250-825-7
I01-6374
IDI1_000834
KBio1_000834
KBio2_002082
KBio2_004650
KBio2_007218
|
KBio3_001474
KBioGR_001270
KBioSS_002082
KO1173
KO-1173
KOE-1173
Lopac0_000784
LS-68257
Mexiletene
Mexiletina
Mexiletina [INN-Spanish]
Mexiletine
Mexilétine
Mexiletine (INN)
Mexiletine [INN:BAN]
Mexiletine HCL
Mexiletine hydrochloride
Mexiletinum
Mexiletinum [INN-Latin]
Mexilitine
Mexitil
Mexitil PL
Mexityl
MolPort-001-790-944
NCGC00015659-04
NCGC00162253-01
NCGC00162253-02
NINDS_000834
novo Mexiletine
novo-Mexiletine
Novopharm brand OF mexiletine hydrochloride
Prestwick0_000241
Prestwick1_000241
Prestwick2_000241
Prestwick3_000241
SBB070242
SPBio_002241
Spectrum_001602
Spectrum3_000727
Spectrum4_000795
Spectrum5_001279
UNII-1U511HHV4Z
|
|
15 |
|
Hormones |
|
Phase 2 |
|
|
|
16 |
|
Calcium, Dietary |
|
Phase 2 |
|
|
|
17 |
|
calcium channel blockers |
|
Phase 2 |
|
|
|
18 |
|
Sodium Channel Blockers |
|
Phase 2 |
|
|
|
19 |
|
Diuretics, Potassium Sparing |
|
Phase 2 |
|
|
|
20 |
|
Calcium |
Nutraceutical |
Phase 2 |
|
7440-70-2 |
271 |
Synonyms:
Blood coagulation factor XIII
Ca
Ca(2+)
Ca2+
Calcio
Calcium
Calcium element
CALCIUM ion
Calcium, doubly charged positive ion
Calcium, elemental
Coagulation factor XIII
Elemental calcium
Factor XIII
|
Factor XIII a chain
Factor XIII a-chain
Factor XIII transamidase
Factor XIII, coagulation
Fibrin stabilizing factor
Fibrinase
Kalzium
Laki lorand factor
Laki-lorand factor
Stabilizing factor, fibrin
Transamidase, factor XIII
XIII, coagulation factor
|
|
21 |
|
Flumazenil |
Approved |
|
|
78755-81-4 |
3373 |
Synonyms:
[3H]Ro15-1788
4H-Imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylic acid, 8-fluoro-5,6-dihydro-5-methyl-6-oxo-, ethyl ester
78755-81-4
8-Fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester
AC1L1FSE
AC1Q33UE
AC-6846
Anexate
Anexic acid
BIDD:GT0766
Biomol-NT_000285
BPBio1_001190
BRD-K98769987-001-01-3
BRN 4763661
C07825
C15H14FN3O3
CHEBI:5103
CHEMBL407
CID3373
CPD000058450
D005442
D00697
DB01205
Ethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylate
Ethyl 8-fluoro-5-methyl-5,6-dihydro-6-oxo-4H-imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylate
ethyl 8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
Ethyl 8-fluoro-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
EU-0100506
F 6300
F6300_SIGMA
flumazenil
Flumazenil
Flumazenil (JAN/USP/INN)
Flumazenil [USAN:BAN:INN]
Flumazenilo
Flumazenilo [Spanish]
Flumazenilum
Flumazenilum [Latin]
Flumazepil
Flumazepil, Ro 15-1788, Anexate, Lanexat, Mazicon, Roma,Flumazenil
HMS2051D17
HMS2089B15
Hoffman la roche brand OF flumazenil
Hoffman La Roche Brand of Flumazenil
|
Hoffman-la roche brand OF flumazenil
Hoffman-La Roche Brand of Flumazenil
I01-0379
Lanexat
Lopac0_000506
Lopac-F-6300
LS-77778
Mazicon
MLS000028850
MLS000759529
MLS001076354
MolPort-003-666-855
NCGC00015439-01
NCGC00015439-03
NCGC00015439-07
NCGC00025116-01
NCGC00025116-02
NCGC00025116-03
NCGC00025116-04
NCGC00025116-05
nchembio747-comp37
PDSP1_001778
PDSP2_001761
Ro 15 1788
Ro 151788
Ro 15-1788
Ro-?15-1788
Ro15-1788
Ro-15-1788
RO-151788
Roche brand OF flumazenil
Roche Brand of Flumazenil
Romazicon
Romazicon (TN)
S1332_Selleck
SAM001246763
SBB063113
SMR000058450
TL8005362
Tocris-1328
UNII-40P7XK9392
UPCMLD-DP137
UPCMLD-DP137:001
ZINC00001464
|
|
22 |
|
Dopamine |
Approved |
|
|
51-61-6, 62-31-7 |
681 |
Synonyms:
(3H)-Dopamine
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-dihydroxyphenyl)ethylamine
2-(3,4-Dihydroxyphenyl)ethylamine
2-benzenediol
3,4 Dihydroxyphenethylamine
3,4-dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-aminoethyl)catechol
4-(2-Aminoethyl)catechol
4-(2-aminoethyl)pyrocatechol
4-(2-aminoethyl)-pyrocatechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)-pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
a-(3,4-Dihydroxyphenyl)-b-aminoethane
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
ASL 279
BIDD:ER0506
Biomol-NT_000001
BPBio1_001123
BSPBio_001932
C03758
CHEBI:18243
CHEMBL59
CID681
cMAP_000036
cMAP_000065
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
dopamine
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopamine hydrochloride
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydrochloride, dopamine
|
Hydroxytyramin
hydroxytyramine
Hydroxytyramine
IDI1_000780
intropin
Intropin
Intropin [*hydrochloride*]
IP 498
KBio1_000780
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L000232
L-DOPAMINE
LDP
Lopac0_000586
Lopac-H-8502
LS-159
Medopa (TN)
m-Hydroxytyramine hydrochloride
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
Spectrum_001012
SPECTRUM1505155
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
ST048774
STK301601
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
|
|
23 |
|
Baclofen |
Approved |
|
|
1134-47-0 |
2284 |
Synonyms:
( inverted question mark)-Baclofen
(?)-Baclofen
(+-)-Baclofen
(+/-)- beta-(Aminoethyl)-4- chlorobenzenepropanoic acid
(+/-)-BACLOFEN
(+/-)-beta-(Aminomethyl)-4-chlorobenzenepropanoic acid
1134-47-0
4-Amino-3-(4-chlorophenyl)butanoic acid
4-amino-3-(4-Chlorophenyl)butyrate
4-amino-3-(4-Chlorophenyl)butyric acid
4-Amino-3-(4-chlorophenyl)butyric acid
62594-36-9
AB00051921
AC1L1DC6
AC-4530
Alphapharm brand OF baclofen
Alphapharm Brand of Baclofen
apo Baclofen
Apo Baclofen
apo-Baclofen
ApoBaclofen
Apo-Baclofen
Apotex brand OF baclofen
Apotex Brand of Baclofen
Ashbourne brand OF baclofen
Ashbourne Brand of Baclofen
ASTA medica brand OF baclofen
ASTA Medica Brand of Baclofen
Athena brand OF baclofen
Athena Brand of Baclofen
Atrofen
AWD, baclofen
AWD, Baclofen
B 5399
b-(4-Chlorophenyl)gaba
b-(Aminomethyl)-4-chlorobenzenepropanoate
b-(Aminomethyl)-4-chlorobenzenepropanoic acid
b-(Aminomethyl)-P-chlorohydrocinnamate
b-(Aminomethyl)-P-chlorohydrocinnamic acid
b-(P-Chlorophenyl)-g-aminobutyrate
b-(P-Chlorophenyl)-g-aminobutyric acid
B3343
B5399_SIGMA
Ba 34647
Ba34,647
Ba-34,647
Ba34647
Ba-34647
baclofen
Baclofen
Baclofen (JP15/USP/INN)
Baclofen (R,S)
Baclofen [USAN:INN:BAN:JAN]
Baclofen alphapharm brand
Baclofen Alphapharm Brand
Baclofen apotex brand
Baclofen Apotex Brand
Baclofen ashbourne brand
Baclofen Ashbourne Brand
Baclofen athena brand
Baclofen Athena Brand
Baclofen awd
Baclofen AWD
Baclofen ciba-geigy brand
Baclofen Ciba-Geigy Brand
Baclofen irex brand
Baclofen Irex Brand
Baclofen isis brand
Baclofen Isis Brand
Baclofen medtronic brand
Baclofen Medtronic Brand
Baclofen novartis brand
Baclofen Novartis Brand
Baclofen nu-pharm brand
Baclofen Nu-Pharm Brand
Baclofen pharmascience brand
Baclofen Pharmascience Brand
Baclofene
Baclofène
Baclofene [INN-French]
Baclofene Irex
Baclofène irex
BaclofeneIrex
Baclofene-Irex
Baclofène-irex
BaclofèneIrex
Baclofeno
Baclofeno [INN-Spanish]
Baclofenum
Baclofenum [INN-Latin]
Baclon
Baclophen
Baclospas
Benzenepropanoic acid, beta-(aminomethyl)-4-chloro-(9CI)
beta-(4-Chlorophenyl)gaba
beta-(Aminomethyl)-4-chlorobenzenepropanoate
beta-(Aminomethyl)-4-chlorobenzenepropanoic acid
beta-(Aminomethyl)-P-chlorohydrocinnamate
beta-(Aminomethyl)-p-chlorohydrocinnamic acid
beta-(Aminomethyl)-P-chlorohydrocinnamic acid
beta-(P-Chlorophenyl)-gamma-aminobutyrate
beta-(p-Chlorophenyl)-gamma-aminobutyric acid
beta-(P-Chlorophenyl)-gamma-aminobutyric acid
Biomol-NT_000251
BPBio1_000012
BPBio1_000750
BRD-A84174873-001-05-2
BRN 2104494
BSPBio_000010
BSPBio_001880
C 34647Ba
C10H12ClNO2
CCRIS 3722
CHEBI:2972
CHEMBL701
Chlorophenyl gaba
Chlorophenyl GABA
Ciba 34,647-Ba
Ciba geigy brand OF baclofen
Ciba Geigy Brand of Baclofen
CIBA34,647ba
|
CIBA-34,647-ba
CIBA34,647BA
CIBA-34,647-BA
Ciba-geigy brand OF baclofen
Ciba-Geigy Brand of Baclofen
CID2284
Clofen
D001418
D00241
DB00181
DivK1c_000001
DL-4-amino-3-P-Chlorophenylbutanoate
DL-4-amino-3-P-Chlorophenylbutanoic acid
DL-4-Amino-3-p-chlorophenylbutanoic acid
DL-Baclofen
EINECS 214-486-9
EU-0100163
GABA, chlorophenyl
GABA, Chlorophenyl
Gabalon
g-amino-b-(P-Chlorophenyl)butyrate
g-amino-b-(P-Chlorophenyl)butyric acid
gamma-amino-beta-(P-Chlorophenyl)butyrate
gamma-amino-beta-(P-Chlorophenyl)butyric acid
gamma-Amino-beta-(p-chlorophenyl)butyric acid
Gen baclofen
Gen Baclofen
Gen-baclofen
GenBaclofen
Gen-Baclofen
Genpharm
HMS1568A12
HMS1920E21
HMS2091M03
HMS500A03
I01-1934
IDI1_000001
Irex brand OF baclofen
Irex Brand of Baclofen
Isis brand OF baclofen
Isis Brand of Baclofen
KBio1_000001
KBio2_000466
KBio2_003034
KBio2_005602
KBio3_001380
KBioGR_000650
KBioSS_000466
Kemstro
Kemstro (TN)
L000002
Lebic
Lioresal
Liorésal
Lioresal (TN)
Lioresal Intrathecal
Lopac0_000163
LS-77134
Medtronic brand OF baclofen
Medtronic Brand of Baclofen
MLS000028480
MolPort-002-051-370
NCGC00015156-05
NCGC00015156-12
NCGC00023843-03
NCGC00024579-03
NCGC00024579-04
NCGC00024579-05
NCGC00024579-06
NINDS_000001
Novartis brand OF baclofen
Novartis Brand of Baclofen
NSC329137
Nu baclo
Nu Baclo
Nu pharm brand OF baclofen
Nu Pharm Brand of Baclofen
Nu-baclo
NuBaclo
Nu-Baclo
Nu-Baclofen
Nu-pharm brand OF baclofen
Nu-Pharm Brand of Baclofen
Oprea1_440627
PCP-GABA
Pharmascience brand OF baclofen
Pharmascience Brand of Baclofen
PMS Baclofen
Pms-Baclofen
PMSBaclofen
PMS-Baclofen
Prestwick_85
Prestwick0_000085
Prestwick1_000085
Prestwick2_000085
Prestwick3_000085
SMP1_000036
SMR000058294
SPBio_000044
SPBio_001949
Spectrum_000066
SPECTRUM1500135
Spectrum2_000092
Spectrum3_000310
Spectrum4_000245
Spectrum5_000852
STK535284
STOCK2S-30552
UNII-H789N3FKE8
UPCMLD-DP142
UPCMLD-DP142:001
β-(4-chlorophenyl)gaba
β-(aminomethyl)-4-chlorobenzenepropanoate
β-(aminomethyl)-4-chlorobenzenepropanoic acid
β-(aminomethyl)-P-chlorohydrocinnamate
β-(aminomethyl)-P-chlorohydrocinnamic acid
β-(P-chlorophenyl)-γ-aminobutyrate
β-(P-chlorophenyl)-γ-aminobutyric acid
γ-amino-β-(P-chlorophenyl)butyrate
γ-amino-β-(P-chlorophenyl)butyric acid
|
|
24 |
|
Mung bean |
Approved |
|
|
|
|
25 |
|
Acetylcholine |
Approved, Investigational |
|
|
51-84-3 |
187 |
Synonyms:
2-(Acetyloxy)-N,N,N-trimethylethanaminium
Acetilcolina cusi
Acetyl choline ion
Acetylcholine bromide
Acetylcholine cation
acetylcholine chloride
Acetylcholine chloride
Acetylcholine fluoride
Acetylcholine hydroxide
Acetylcholine iodide
Acetylcholine L tartrate
Acetylcholine L-tartrate
Acetylcholine perchlorate
Acetylcholine picrate
Acetylcholine picrate (1:1)
Acetylcholine sulfate (1:1)
Acetylcholinium: acetyl-choline
ACh
Alcon brand OF acetylcholine chloride
|
Azetylcholin
Bournonville brand OF acetylcholine chloride
Bromide, acetylcholine
Bromoacetylcholine
Chloroacetylcholine
Choline acetate
Choline acetate (ester)
Choline acetic acid
Ciba vision brand OF acetylcholine chloride
Cusi, acetilcolina
Fluoride, acetylcholine
Hydroxide, acetylcholine
Iodide, acetylcholine
Iolab brand OF acetylcholine chloride
L-Tartrate, acetylcholine
Miochol
O-Acetylcholine
Perchlorate, acetylcholine
|
|
26 |
|
Insulin, Globin Zinc |
|
|
|
|
|
27 |
|
insulin |
|
|
|
|
|
28 |
|
GABA Agonists |
|
|
|
|
|
29 |
|
Botulinum Toxins |
|
|
|
|
|
30 |
|
Cholinergic Agents |
|
|
|
|
|
31 |
|
Neurotransmitter Agents |
|
|
|
|
|
Interventional clinical trials:
(show top 50)
(show all 79)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
An Open Label Evaluation of MIDI to Quantify Performance Change in Subjects With Musician's Dystonia After Treatment With Botulinum Toxin Type B (Myobloc ®). |
Completed |
NCT00208091 |
Phase 4 |
Botulinum toxin, type B |
2 |
Golfer's Cramp: Correlation of Wrist Movements and Surface EMG With Putter Movements |
Completed |
NCT02032758 |
Phase 4 |
Propranolol |
3 |
An Open-Label, Non-Inferiority Study Evaluating the Efficacy and Safety of Two Injection Schedules of Xeomin® (incobotulinumtoxinA) [Short Flex Versus Long Flex] in Subjects With Cervical Dystonia With < 10 Weeks of Benefit From OnabotulinumtoxinA Treatment |
Completed |
NCT01486264 |
Phase 4 |
|
4 |
Comparison of Electrophysiologic and Ultrasound Guidance for Onabotulinum Toxin A Injections in Focal Upper Extremity Dystonia and Spasticity |
Completed |
NCT02326818 |
Phase 3 |
|
5 |
IncobotulinumtoxinA (Xeomin) to Treat Focal Hand Dystonia: a Double-blind Placebo-controlled Randomized Multicenter Study: The "SwissHandSpasm" Study |
Recruiting |
NCT03977493 |
Phase 3 |
Xeomin;Placebo - Concentrate |
6 |
Use of Botulinum Toxin (BTX) for the Treatment of Peripheral Painful Traumatic Trigeminal Neuropathy (PPTTN) |
Recruiting |
NCT03555916 |
Phase 3 |
BOTOX®, Allergan;Placebo |
7 |
Placebo Controlled Study of the Therapeutic Effect of the Transcranial Electrical Polarization in Patients With Focal Hand Dystonia |
Completed |
NCT00106782 |
Phase 2 |
|
8 |
Effectiveness of rTMS and Retraining in the Treatment of Focal Hand Dystonia |
Completed |
NCT01738581 |
Phase 1, Phase 2 |
|
9 |
Motor Training as Treatment of Focal Hand Dystonia |
Completed |
NCT00021853 |
Phase 2 |
|
10 |
Trial of Amlodipine Combined With Botulinum Toxin Injections for Focal Dystonia |
Completed |
NCT00015457 |
Phase 2 |
Amlodipine plus Botulinum toxin |
11 |
Pilot Trial of Botulinum Toxin and Occupational Therapy for Writer's Cramp |
Completed |
NCT02015039 |
Phase 1, Phase 2 |
BoNT Injections |
12 |
Mexiletine for the Treatment of Focal Dystonia |
Completed |
NCT00001784 |
Phase 2 |
Mexiletine |
13 |
A Study of Acetyl Hexapeptide-8 (AH8) in Treatment of Blepharospasm |
Completed |
NCT00942851 |
Phase 1, Phase 2 |
Acetyl-Hexapeptide Topical Treatment;placebo |
14 |
Blepharospasm and the Experimental Modulation of Cortical Excitability in Primary and Secondary Motor Areas. A Pilot Study. |
Completed |
NCT00411255 |
Phase 2 |
|
15 |
An Open-label Phase 2a Study to Evaluate the Safety and Tolerability of Perampanel (E2007) in Subjects With Cervical Dystonia (SAFE-Per CD) |
Completed |
NCT02131467 |
Phase 1, Phase 2 |
Perampanel |
16 |
A Placebo-Controlled, Double-Blind, Randomized, Cross Over Pilot Study Of The Efficacy And Tolerability Of Incobotulinum Toxin A (Xeomin®) As A Treatment For Focal Task-Specific Dystonia Of The Musician's Hand |
Recruiting |
NCT02107261 |
Phase 2 |
incobotulinumtoxin A |
17 |
Deep Brain Stimulation Surgery for Treatment of Focal Hand Dystonia |
Recruiting |
NCT02911103 |
Phase 1, Phase 2 |
|
18 |
Placebo Controlled Double Blind Study of Acetyl Hexapeptide-8 in Treatment of Blepharospasm |
Terminated |
NCT01750346 |
Phase 2 |
Topical acetyl hexapeptide-8;Placebo |
19 |
Multiple Sessions of Low-frequency Repetitive Transcranial Magnetic Stimulation in Focal Hand Dystonia: Clinical and Physiological Effects |
Completed |
NCT01884064 |
Phase 1 |
|
20 |
Motor and Premotor Cortex Stimulation for Treatment of Secondary Focal Dystonia With Striato Pallidal Lesion : Evaluation of Safety and Effectiveness |
Completed |
NCT00505323 |
Phase 1 |
|
21 |
Tactile Operant Conditioning To Alleviate Focal Hand Dystonia Symptoms |
Unknown status |
NCT00579033 |
|
|
22 |
The Influence of Gaze Shift and Emotions on Symptoms of Blepharospasm- a Pilot Study. |
Unknown status |
NCT01759745 |
|
|
23 |
Corticomotor Plasticity as a Biomarker for Functional Improvement After Botulinium Treatment in Writer's Cramp |
Unknown status |
NCT03085745 |
|
|
24 |
fMRI Studies of Task Specificity in Focal Hand Dystonia |
Completed |
NCT00310414 |
|
|
25 |
Neurophysiology of Task-Specificity of Focal Hand Dystonia |
Completed |
NCT00309010 |
|
|
26 |
Evaluation of Density and Pattern of Distribution of GABA A Receptors in the Brain of Patients With Focal Hand Dystonia Studied With PET Using [11C] Flumazenil |
Completed |
NCT00306865 |
|
|
27 |
EEG Study of Movement-Related Center-Surround Organization in Hand Dystonia |
Completed |
NCT00025701 |
|
|
28 |
Impact Of Physiotherapy And Botulinum Toxin Type-A In Improving Functional Outcomes In Upper Limb Focal Dystonia Among Post Stroke Patients |
Completed |
NCT03664375 |
|
|
29 |
Long-Term Motor Learning in Focal Hand Dystonia |
Completed |
NCT00325091 |
|
|
30 |
The Role of Cortical Coherence in Focal Hand Dystonia |
Completed |
NCT00137384 |
|
|
31 |
The Effect of Peripheral Heterotopic Stimulation on Cortical Excitability in Dystonia |
Completed |
NCT00050024 |
|
|
32 |
The Association Between Focal Dystonia (FD) and Complex Regional Pain Syndrome (CRPS) |
Completed |
NCT00595439 |
|
|
33 |
Sensory Training for Treatment of Focal Dystonia |
Completed |
NCT00006336 |
|
|
34 |
Role of Neurotransmission and Functional CNS Networks in Spasmodic Dysphonia and Other Focal Dystonias |
Completed |
NCT00713414 |
|
|
35 |
Survey of Sensory and Motor Tricks in Focal Dystonia |
Completed |
NCT00054652 |
|
|
36 |
The Effect of Surround Inhibition During Phasic Compared to Tonic Voluntary Finger Movement in Focal Hand Dystonia |
Completed |
NCT00376753 |
|
|
37 |
Movement Disorder Survey in East China |
Completed |
NCT01168388 |
|
|
38 |
Characterization of Manual Dexterity by Finger Force Manipuladum (FFM) in Patients With Writer's Cramp and in Control Subjects |
Completed |
NCT03797638 |
|
|
39 |
Repetitive Transcranial Magnetic Stimulation in Spasmodic Dysphonia |
Completed |
NCT02957942 |
|
|
40 |
Neurophysiological Studies of Focal and Generalized Forms of Dystonia Using Transcranial Magnetic Stimulation (TMS) |
Completed |
NCT00017875 |
|
|
41 |
Role of Dopamine Receptors in Primary Focal Dystonias |
Completed |
NCT01373840 |
|
|
42 |
Validating a New Writer's Cramp Scale |
Completed |
NCT01579266 |
|
|
43 |
Functional Connectivity of the Basal Ganglia in Primary Focal Dystonia |
Completed |
NCT01761903 |
|
|
44 |
Neurophysiological Markers in Patients With Craniofacial Dystonia and Their Relatives |
Completed |
NCT00082615 |
|
|
45 |
The Study of Surround Inhibition in Patients With Dystonia |
Completed |
NCT00029601 |
|
|
46 |
Combined Effects of rTMS and Botulinum Toxin in Benign Essential Blepharospasm: A Novel Approach |
Completed |
NCT02370875 |
|
|
47 |
Computer Modelling of the Cervical Spine Movements in Cervical Dystonia |
Completed |
NCT02894359 |
|
|
48 |
Brain Connectivity and Sensorimotor Integration During Dual/Single Motor Tasks |
Completed |
NCT00498329 |
|
|
49 |
The Physiology of Tricks |
Completed |
NCT00072956 |
|
|
50 |
Comparative Study Between the Functional Outcomes of Neuromodulation and Neuroablation Techniques for Treatment of Secondary Dystonia |
Completed |
NCT03347240 |
|
|
|